| Circulating C1q levels in health and disease, more than just a biomarker FS van de Bovenkamp, DJ Dijkstra, C van Kooten, KA Gelderman, ... Molecular Immunology 140, 206-216, 2021 | 31 | 2021 |
| Complement activation and regulation in rheumatic disease DJ Dijkstra, JV Joeloemsingh, IM Bajema, LA Trouw Seminars in immunology 45, 101339, 2019 | 22 | 2019 |
| Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patients R Lubbers, JS Sutherland, D Goletti, RA De Paus, DJ Dijkstra, ... Molecular immunology 120, 187-195, 2020 | 20 | 2020 |
| PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation DP Noone, DJ Dijkstra, TT van der Klugt, PA van Veelen, AH de Ru, ... Proceedings of the National Academy of Sciences 119 (33), e2208144119, 2022 | 17 | 2022 |
| Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains L Abendstein, DJ Dijkstra, RTN Tjokrodirijo, PA van Veelen, LA Trouw, ... Nature Communications 14 (1), 4027, 2023 | 11 | 2023 |
| Carbamylation reduces the capacity of IgG for hexamerization and complement activation R Lubbers, SC Oostindie, DJ Dijkstra, PWHI Parren, MK Verheul, ... Clinical & Experimental Immunology 200 (1), 1-11, 2020 | 11 | 2020 |
| Circulating levels of anti-C1q and anti-factor H autoantibodies and their targets in normal pregnancy and preeclampsia DJ Dijkstra, AI Lokki, LM Gierman, NV Borggreven, C van der Keur, ... Frontiers in Immunology 13, 842451, 2022 | 6 | 2022 |
| Inverse correlation between serum complement component C1q levels and whole blood type‐1 interferon signature in active tuberculosis and QuantiFERON‐positive uveitis … B Schrijver, DJ Dijkstra, NV Borggreven, R La Distia Nora, E Huijser, ... Clinical & Translational Immunology 9 (10), e1196, 2020 | 5 | 2020 |
| Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation DJ Dijkstra, FS van de Bovenkamp, L Abendstein, R Zuijderduijn, J Pool, ... Proceedings of the National Academy of Sciences 120 (50), e2310666120, 2023 | 1 | 2023 |
| Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q P Niewold, DJ Dijkstra, Y Cai, D Goletti, F Palmieri, KE van Meijgaarden, ... Scientific Reports 13 (1), 11617, 2023 | | 2023 |
| DNA nanostructure-templated antibody complexes provide insights into the geometric requirements of human complement cascade activation L Abendstein, W Noteborn, L Veenman, D Dijkstra, F Bovenkamp, ... bioRxiv, 2023.10. 20.562751, 2023 | | 2023 |
| Anti‐C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single‐centre, cross‐sectional study DJ Dijkstra, SIE Liem, NM van Leeuwen, CM Fehres, ... British Journal of Dermatology 185 (3), 657-658, 2021 | | 2021 |
